M12 has co-led a $34m round for Ox Security’s while SoftBank-backed Solfácil has upped its series C to $130m.
This week's key deals included Ryan Reynolds' Maximum Effort Holdings helping Bending Spoons raise $340m, while GV moves beyond its algorithm and Milan emerges as a startup hub.
Maximum Effort Holdings was part of a $340m round for Bending Spoons while Tencent and Block took part in Satispay's $310m series D.
Where does corporate VC fit into food and agriculture in 2022? Global Venturing asked industry figures at one of Europe's largest agricultural technology conferences to find out.
Gradient Ventures and Workday Ventures were part of Flatfile’s $50m series B round while KPN Ventures is set to exit ZecOps through an acquisition.
Tata Digital provided $200m for BigBasket while Convivialité Ventures took part in an $80m series B round for Not So Dark.
FTX-backed PayUp agreed to merge with IG Acquisition while multiple corporates participated in Line Man Wongnai’s $265m series B round.
RxCelerate took part in Rivus Pharmaceuticals’ $132m series B round while Bank of America and Citi backed AccessFintech’s $60m series C.
Beauty treatments, medical procedures and personalisation are blending together, with China at the forefront of these key trends.
Brevan Howard Digital has led a $35m series B round for Messari while Robert Bosch Venture Capital participated in Tulu’s $25m series A.
Novo Holdings led a $75m series C round for Kate Farms while PayU and InfoEdge Ventures participated in DotPe’s $58m series B.
Alphabet led a $1bn round for its life sciences unit, PTT bets on insect startup and corporate-backed Propzy is set to shut down.
Pfizer Ventures has led a $102m series A for Capstan Therapeutics while Globis Capital Partners took part in an $85.4m round for Andpad.
Access Industries, Pfizer and SR One were among the investors in a $125m round for Nimbus Therapeutics while Aerwins agreed a reverse takeover.
Where does corporate VC fit into food and agriculture in 2022? Global Venturing asked industry figures at one of Europe's largest agricultural technology conferences to find out.
Beauty treatments, medical procedures and personalisation are blending together, with China at the forefront of these key trends.
Alphabet led a $1bn round for its life sciences unit, PTT bets on insect startup and corporate-backed Propzy is set to shut down.
Hitachi grows its cell therapy portfolio, SoftBank slims down in India and Foresight Williams backs ID tags for diamonds.
Global Corporate Venturing (GCV) is where global innovation and capital converge to define, invest and shape the world of tomorrow. We provide the world’s investors and the wider innovation ecosystem with the information, insights, collaboration and access they need to succeed in a constantly changing world.
